A Genetic Modifier of the Gut Microbiome Influences the Risk of Graft-versus-Host Disease and Bacteremia After Hematopoietic Stem Cell Transplantation
详细信息 查看全文
- 作者：Ahmad Rayes1 ; ahmad.rayes@cchmc.org" class="auth_mail" title="E-mail the corresponding author ; Ardythe L. Morrow2 ; Leslie R. Payton1 ; Kelly E. Lake1 ; Adam Lane1 ; 3 ; Stella M. Davies1
- 关键词：Fucosyltransferase 2 ; FUT2 ; Microbiome ; Graft-versus-host disease ; Bacteremia ; Hematopoietic stem cell transplantation
- 刊名：Biology of Blood and Marrow Transplantation
- 出版年：2016
- 出版时间：March 2016
- 年：2016
- 卷：22
- 期：3
- 页码：418-422
- 全文大小：474 K
文摘
- •
Disturbances of the human gut microbiome have been shown to lead to development of inflammatory conditions
- •
Fucosyltransferase 2, a genetic modifier of the human gut microbiome, influences the risk of graft-versus-host disease after hematopoietic stem cell transplantation
- •
Fucosyltransferase 2, a genetic modifier of the human gut microbiome, influences the risk of bacteremia after hematopoietic stem cell transplantation